Back
Speaker illustration

undefined undefined undefined

Presentations

Association Between Comorbidity Burden and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Insights from the CABANA Trial

Event: ESC Congress 2025

Topic: Catheter Ablation of Arrhythmias

Session: Heart failure ablation

Access
Like
Thumbnail

Identifying at-risk patients for atrial high-rate episodes by machine learning

Event: ESC Congress 2024

Topic: Artificial Intelligence

Session: Artificial intelligence-powered cardiovascular risk assessment: machine learning for disease detection

Access
Like
Thumbnail

Implications of renal function on adverse clinical events in patients with atrial fibrillation: a comparative analysis of VKA and NOAC therapy - Insights from the GLORIA-AF Registry Phase III

Event: ESC Congress 2024

Topic: Oral Anticoagulation

Session: Management of comorbidities and outcomes in atrial fibrillation (2)

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources